Online ISSN 2313-1519
Print    ISSN 1812-2892
Abstract - Sensorineural hearing loss after bacterial meningitis in children
[PDF]            [Full text/HTML]           
Aliya Seidullayeva, Gulnar Zhaxylykova, Dinagul Bayesheva, Raisa Sundetova, Bulat Aitzhanov, Almagul Orymbayeva


Sensorineural hearing loss – form of hearing loss up to its total loss at which any of the sites of the sound-receiving part can be damaged. The most important problem of patients with sensorineural hearing loss is lack of effective treatment and inability to restore hearing because 80% of patients who suffered from bacterial meningitis loss of hearing is accompanied by ossification of internal ear structures. However, bacterial meningitis is still registered in Kazakhstan and is a reason of development of sensorineural hearing loss and often accompanied by ossification of internal ear structures in children and adults leading to long-term neurological lesions, such as hearing impairments or hearing loss. For early diagnosis of hearing loss in children with bacterial meningitis, an audiological examination should be performed in the first 48 hours from the onset of the disease and after discharge from the hospital for 1 year. To date, the only effective method of hearing restoration is surgery – cochlear implantation. This review of the literature is devoted to one of the actual complications of bacterial meningitis – sensorineural deafness in children.

Keywords: bacterial meningitis, sensorineural hearing loss, children, S.pneumoniae, H.influenzae, N.meningitidis.


1. Morton N. Swartz. Bacterial Meningitis. А View of the Past 90 Year. Engl. J. Med. 2004; 351:18.1826.

2. Seidullaeva A.Zh. Epidemiologicheskaya kharakteristika bakterial'nykh meningitov u detei na sovremennom etape. (Epidemiological characteristics of bacterial meningitis in children at the present stage). Astanalyқ meditsina zhurnaly. 2017;2: 29-38.

3. Bhasin TK, Brocksen S, Avchen RN, Braun KV. Prevalence of four developmental disabilities among children aged 8 years: Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000. US Department of Health and Human Services, Centers for Disease Control and Prevention. MMWR Surveill. Summ. 2006; 55: 1-9.

4. Kutz JW, Simon LM, Chennupati SK, Giannoni CM, Manolidis S. Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg. 2006; 132(9):941–945.

5. Van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. New England Journal of Medicine. 2004;351(18):1849-59.

6. Wellman MB, Sommer DD, McKenna J. Sensorineural hearing loss in postmeningitic children. Otol Neurotol. 2003;24:907-912.

7. Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, van Furth AM. Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. Pediatrics. 2003; 112:1049-1153.

8. Swartz MN. Bacterial meningitis—a view of the past 90 years. New England Journal of Medicine. 2004;351(18):1826-8.

9. Duan K, Guo J, Lei P. Safety and Immunogenicity of Pneumococcal Conjugate Vaccine in Preterm Infants: A Meta-Analysis. Indian J Pediatr. 2017; 84(2):101–110.11.

10. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010; 14: e197-e209.

11. Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States. Antimicrob Agents Chemother. 2014;58:6484.

12. Türel Ö, Yıldırım C, Yılmaz Y, Külekçi S, Akdaş F, Bakır M. Clinical Characteristics and Prognostic Factors in Childhood Bacterial Meningitis: A Multicenter Study. Balkan Med J. 2013;30:80-4.

13. De Jonge RC, Van Furth AM, Wassenaar M, Gemke RJ, Terwee CB Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis. 2010;10:232.

14. Koroljova M.A. Jepidemiologicheskij monitoring za gnojnymi bakterial'nymi meningitami v RF (Epidemiological monitoring of purulent bacterial meningitis in the Russian Federation). Diss. rabota. Moskva. 2014.

15. Daza, P., Banda, R., Misoya, K., Katsulukuta, A., Gessner, B.D., Katsande, R., et al. The impact of routine infant immunisation with haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine. 2006; 24:6232-6239.

16. World Health Organization. World health statistics 2015. World Health Organization; 2015 May 14.

17. Brouwer M. C., Tunkel A. R., and van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical Microbiology Reviews. 2010; vol. 23, no. 3, pp. 467–492.

18. A. Davis and K. Davis, "Descriptive epidemiology of childhood hearing impairment," in Comprehensive Handbook of Pediatric Audiology. R. Seewald and A. M. Tharpe, Eds., ed San Diego: Plural Publishing, 2011; pp. 85-111.

19. L. J. Baraff, S. I. Lee, and D. L. Schriger. Outcomes of bacterial meningitis in children: a meta-analysis, Pediatric Infectious Disease Journal. 1993;2:389-394.

20. A. Chandran, H. Herbert, D. Misurski, and M. Santosham. dLong-term sequelae of childhood bacterial meningitis an underappreciated problem, The Pediatric Infectious Disease Journal. 2011.vol. 30, pp. 3-6.

21. E. Husain, R. Chawla, S. Dobson, and H. D. Davies, Epidemiology and outcome of bacterial meningitis in Canadian children: 1998-1999. Clinical and Investigative Medicine. 2006; 29:131-135.

22. D. Philippon, F. Bergeron, P. Ferron, and R. Bussi`eres, Cochlear implantation in postmeningitic deafness. Otology and Neurotology.2010; 31, no. 1:83–87.

23. Kesser BW, Hashisaki GT, Spindel JH, Ruth RA, Scheld WM Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg. 1999; 120(5):628–637.

24. A. Douglas, H. Sanli, and W. P. R. Gibson. Meningitis resulting in hearing loss and labyrinthitis ossificans—does the causative organism matter. Cochlear Implants International. 2008; 9, no. 2: 90–96.

25. Hinojosa R, Redleaf MI, Green Jr JD, Blough RR. Spiral ganglion cell survival in labyrinthitis ossificans: computerized image analysis. The Annals of otology, rhinology & laryngology. Supplement. 1995;166:51-4.

26. Rotteveel LJ, Snik AF, Vermeulen AM, Mylanus EA. Three-year follow-up of children with postmeningitic deafness and partial cochlear implant insertion. Clin Oto laryngol. 2005; 30(3):242–248.

27. M. Cosetti and J. T. Roland Jr. Cochlear implantation in the very young child: Issues unique to the under-1 population. Trends in Amplification. 2010; vol. 14, no. 1, 46–57.

28. Steenerson RL, Gary LB, Wynens MS. Scalavestibuli cochlear implantation for labyrinthine ossification. Am J Otol 1990;11(5):360–3.

29. Richardson MP, Williamson TJ, Reid A, Tarlow MJ, Rudd PT. Otoacoustic emissions as a screening test for hearing impairment in children recovering from acute bacterial meningitis. Pediatrics. 1998;102(6):1364-8.

30. Durisin M, Arnoldner C, Stover T et al. Audiological performance in cochlear implanted patients deafened by meningitis depending on duration of deafness. Eur. Arch. Otorhinolaryngol. 2008; 265:381–388.

31. Jöhr M, Ho A, Wagner CS, Linder T. Ear surgery in infants under one year of age: its risks and implications for cochlear implant surgery. Otology & Neurotology. 2008;29(3):310-313.

32. Dvustoronnjaja nejrosensornaja tugouhost' (pediatrija). Respublikanskij centr razvitija zdravoohranenija (Two-sided sensorineural hearing loss). Klinicheskie protokoly MZ RK - 2014. Available at:

33. Ovchinnikov JuM, Borodin AA. Opyt operacii kohlearnoj implantacii s implantom Combi 40+ firmy «MED-EL» (Experience of operation of cochlear implantation with a Combi 40+ implant by MED-EL). Vestn. otorinolar. 2001(1):33-36.

34. P. Merkus, R. H. Free, E. A. M. Mylanus et al. Dutch cochlear implant group (CI-ON) consensus protocol on postmeningitis hearing evaluation and treatment. Otology and Neurotology. 2010; 31, no. 8: 1281-1286.

35. Szynczewska E, Chlebna-Sokół D. Immunogenicity of heptavalent conjugate vaccine against Streptococcus Pneumoniae in premature babies with low birth weight. Pediatr Neonatol. 2014;55:101–7.

36. JT. Roland Jr., M. Cosetti, K. H. Wang, S. Immerman, and S.B. Waltzman, Cochlear implantation in the very young child: long-term safety and efficacy. Laryngoscope, 2009; 119, no. 11: 2205–2210.

37. SJ. Dettman, D. Pinder, R. JS. Briggs, RC. Dowell, and J. R. Leigh. Communication development in children who receive the cochlear implant younger than 12 months: risks versus benefits. Ear and Hearing. 2007; 28, supplement 2,11S–18S.

38. L. Colletti, M. Mandal`a, L. Zoccante, R. V. Shannon, and V. Colletti. Infants versus older children fitted with cochlear implants: performance over 10 years. International Journal of Pediatric Otorhinolaryngology. 2011; 75, no.4: 504-509.

39. BCCH Audiology Clinical Practice Guideline Meningitis May 16, 2014. Available at:

40. Pashhina O.A «Osobennosti hirurgicheskogo jetapa kohlearnoj implantacii u pacientov, perenesshih meningit» (Features of the surgical stage of cochlear implantation in patients who underwent meningitis) soikanie uchenoj stepeni k.m.n., Sankt-Peterburg, 2011;60-64.


Volume 4, Number 46 (2017)